Emerging Hallmarks in Cancer Immunology
A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 1 February 2026 | Viewed by 380
Special Issue Editor
Special Issue Information
Dear Colleagues,
Recent advances in immunology have transformed our understanding of various pathophysiological processes, with cancer emerging as a key condition influenced by immune system dynamics. The discovery that immune responses can shape tumor development and be harnessed therapeutically has led to significant progress, particularly in immunotherapy, now a promising strategy in cancer treatment.
This Special Issue will gather scientific articles that deepen our understanding of cancer immunobiology, focusing on immune mechanisms involved in tumor initiation, progression, and control. The selected contributions will shed light on the complex interactions between immune cells and tumor cells, explore immune evasion strategies, and highlight emerging trends in immunotherapeutic approaches.
Furthermore, this Special Issue will integrate multiple areas of biological sciences, such as cell and molecular biology, genetics, microbiology, bioinformatics, and biotechnology, recognizing that interdisciplinary approaches are crucial for advancing both knowledge and clinical application in this field. We look forward to receiving your contributions, promoting the diversity and dynamism of scientific research at the interface of immunity and cancer.
Prof. Dr. Ana Paula Silva de Azevedo-Santos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immune vigilance
- cancer immunoediting
- tumor microenvironment
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
